Clinical Trial Update: 2-Week Study In People With Nonalcoholic Fatty Liver Disease [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update for a two-week study in adults with nonalcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Non-alcoholic Steatohepatitis

Snippet

Sponsor: Pfizer | Conditions: Non-alcoholic Steatohepatitis, Non-alcoholic Fatty Liver Disease | Phase 1 | Status: COMPLETED | Results posted: 2020-03-13